opion, page-2

Vision Systems (VSL) is unquestionably the most impressive local player in the much maligned technology sector.

Their recent long awaited acquisition has met with unanimous acclaim by all discerning posters I've seen.

Institutions and others with short term horizons may be deterred by immediate prospects and opt out.

But VSL are clearly planning for the long term and no one has a better chance of pulling it off.

Remeber they claim to have won every international medical contract R&D deal they bid for last year. How many companies can claim that?